United States
Found is a U.S.-based telehealth platform specializing in personalized weight loss programs, operating its social presence under the handle @joinfound.
Total Followers +0.6%
49K
Across Instagram
Primary Platform
YouTube
49K followers · 100% of audience
Engagement
0.1%
vs. 1.5% category median
Sponsorship Tier
Micro
Est. $1.2K–$3.4K / IG post
U.S. News debuted its inaugural 2026–2027 Best GLP-1 Telehealth Platforms ratings, evaluating 20 platforms across six clinical metrics. Found placed second overall — a distinction the brand has prominently highlighted in its social content.
The study, published in Obesity Science & Practice, found that members using Found's combined medication and behavior-change program achieved clinically significant, lasting weight loss — providing real-world evidence for the telehealth weight-care model.
| Platform | Followers | 30d Growth | Engagement | Posts / wk | Last upload |
|---|---|---|---|---|---|
| 48,675 | +277 | 0.1% | — | 14 days ago |
| Window | Combined | |||
|---|---|---|---|---|
| Last 7 days | +44 +0.1% | +0 +0.0% | +0 +0.0% | +44 |
| Last 30 days | +277 +0.6% | +0 +0.0% | +0 +0.0% | +277 |
| Last 90 days | +827 +1.7% | +0 +0.0% | +0 +0.0% | +827 |
| Last 365 days | +827 +1.7% | +0 +0.0% | +0 +0.0% | +827 |
Daily follower snapshots from CreatorDB's longitudinal index.
Found is a U.S.-based telehealth platform specializing in personalized weight loss programs, operating its social presence under the handle @joinfound. The brand's Instagram functions as a blend of patient education, clinical credibility-building, and community storytelling — featuring collaborations with medical professionals including Dr. Rekha Kumar and educational content around GLP-1 medications and peptide therapies. Content pillars include metabolic health, hormonal shifts such as postpartum and perimenopause, and patient journey narratives, positioning Found as a medically grounded but emotionally resonant voice in the competitive weight-loss telehealth space. The channel actively amplifies third-party recognition, including a top-two GLP-1 telehealth platform ranking from U.S. News.
Found's Instagram audience skews heavily female and concentrates in the 25–44 age band — demographics closely aligned with its clinical focus on hormonal and metabolic conditions that disproportionately affect women in midlife. Engagement sits below category norms, which is typical for brand accounts where conversion and patient acquisition rather than raw interaction drive measurable value. The predominantly U.S. audience, with secondary pockets in the UK and Canada, reflects current telehealth licensing geography. As GLP-1 medications continue moving into mainstream healthcare conversations, Found's social channel is positioned to serve a dual role: a discovery and acquisition funnel for prospective patients and a community retention layer for members already enrolled in its programs.
Joinfound reaches an audience concentrated in United States primarily through YouTube, and is best activated via Instagram Reels and Stories. As a health creator they map naturally to brands targeting that space. Demonstrated partners include joinfound. Engagement on YouTube runs around 0.1%, which points to an audience better suited to category-relevant, mid-funnel campaigns than to pure-reach buys. Their YouTube-first format lends itself to integrations that sit inside the creator's usual content rather than running as standalone ads. Because the audience follows health content rather than arriving through untargeted reach, sponsorships that match the channel's subject matter tend to convert more efficiently than broad placements. A consistent, on-topic posting focus gives sponsors a predictable, brand-safe environment, lowering placement risk compared with broad, general-interest channels. Campaigns here are best measured on qualified engagement and consideration within the niche rather than on raw impression volume. For United States-focused brands in health and related categories, Joinfound offers a defined, creative-fit audience rather than broad, low-intent impressions.
Benchmark estimates for a creator at Joinfound's tier (Micro, 49K combined followers, United States). Pulled from CreatorDB's category benchmarks.
The CreatorDB Agency runs end-to-end influencer campaigns globally — shortlisting, outreach, contracting, and performance reporting. Talk to our team about building a campaign around creators in this niche.
Yes, Found was named the number 2 overall GLP-1 telehealth platform by U.S. News, a recognition the company has highlighted across its social channels. This ranking places Found among the leading online services that connect patients with providers for GLP-1 medication management. It reflects the platform's growing reputation in the competitive telehealth weight loss space.
Found is a GLP-1 telehealth platform that connects members with licensed medical providers who evaluate whether GLP-1 medications are appropriate for their individual situation. The platform uses the hashtag #glp1journey across its content, signaling that GLP-1 treatment is central to what it offers. Whether a specific medication is prescribed depends on your personal health profile and the provider's assessment.
Found's core premise is that weight loss should be tailored to your body rather than a generic plan — their tagline is literally "weight loss, your way, personalized to your body." The platform factors in hormonal influences, metabolic health, and individual circumstances rather than treating all patients the same. This framing sets them apart from one-size-fits-all diet programs.
Found specifically addresses hormonal causes of weight gain in its content, including postpartum and perimenopause, with messaging like "you can't out-discipline a hormonal shift." The platform's position is that weight gained during hormonal transitions requires medical support, not just more willpower. Their personalized care model is designed to account for these biological factors.
Found has featured content where Dr. Rekha Kumar and a peptide specialist discuss what peptides actually are in a metabolic health context, signaling that peptides are part of their treatment conversation. Whether peptide therapy is available as part of your Found plan would depend on your individual provider and health profile. Their content positions peptides as an emerging but serious topic alongside GLP-1 medications.
Dr. Rekha Kumar is a featured medical expert who appears in Found's educational content, including breakdowns of peptides and metabolic health. She is a well-known obesity medicine specialist who has spoken publicly about weight treatment and hormonal metabolism. Her presence in Found's content is intended to give the platform medical authority and credibility.
Found differentiates itself by emphasizing a personalized, whole-body approach to metabolic health rather than positioning itself purely as a prescription delivery service. Their content explicitly covers hormonal factors, peptides, and ongoing care — not just medication access. They also carry an independent ranking from U.S. News as a top GLP-1 telehealth platform, which they use as a third-party credibility signal.
Found is open to all adults, though its social audience and content skew heavily female — with women making up a strong majority of its followers and much of its messaging addressing hormonal issues like perimenopause and postpartum weight gain. That said, metabolic health and GLP-1 treatment are relevant across genders, and the platform does not restrict membership by sex. Men represent a smaller but meaningful share of their audience.
Found is a U.S.-based telehealth platform with the large majority of its audience located in the United States. Telehealth prescribing is subject to state-by-state regulations, so service availability may vary depending on where you live. Checking directly on Found's website is the most reliable way to confirm availability in your specific state.
Found is most active on Instagram under the handle @joinfound, where they post a mix of patient stories, medical expert features, and educational content about GLP-1 medications and metabolic health. They also have a presence on YouTube. Their Instagram content is where they share real member experiences and platform news, including their U.S. News ranking.
Stats (followers, engagement, audience demographics, growth) are pulled live from the CreatorDB API covering YouTube, Instagram and TikTok. Bio and FAQ content is AI-assisted; news items are sourced from cited public press at generation time. Read the full methodology →
If you'd like to update, correct, or remove this profile, get in touch and we'll handle it within 5 business days. We don't publish private data — every stat shown comes from your public platform profiles.
@joinfound · YouTube
+0 new followers
Preparing fresh data…
This usually takes 15–25 seconds.